Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?

E Cosson1, M Guimfack, J Paries

  • 1Department of Endocrinology-Diabetology-Nutrition, Paris-Nord University, Jean Verdier Hospital, AP-HP, Bondy, France. emmanuel.cosson@jvr.ap-hop-paris.fr

Diabetes & Metabolism
|November 25, 2003
PubMed

Insights

Silent coronary stenoses (CS) predict major cardiac events and other cardiovascular events in diabetic patients. These conditions are more common in older males with multiple risk factors.

Area of Science:

  • Cardiology
  • Diabetology
  • Vascular Medicine

Background:

  • Silent coronary stenoses (CS) are established predictors of major cardiac events in diabetic patients with silent myocardial ischemia (SMI).
  • Further investigation is needed to understand the correlates and prognostic value of CS for a broader range of cardiovascular outcomes.

Purpose of the Study:

  • To identify the clinical correlates of silent coronary stenoses (CS) in asymptomatic diabetic patients.
  • To evaluate the prognostic significance of CS for various cardiovascular events beyond major cardiac events.

Main Methods:

  • 362 asymptomatic diabetic patients without prior myocardial infarction and with at least one additional risk factor underwent myocardial scintigraphy to detect SMI.
  • Patients with SMI subsequently underwent coronary angiography to detect CS.
  • Follow-up for 41 months assessed stroke, gangrene, peripheral revascularization, angina, and arrhythmia.

Main Results:

  • Silent myocardial ischemia (SMI) was detected in 121 patients, and silent coronary stenoses (CS) in 44.
  • Independent correlates of CS included age over 65, male gender, and having two or more risk factors.
  • Peripheral arterial disease, smoking, and CS independently predicted cardiovascular events.

Conclusions:

  • Silent coronary stenoses (CS) predict not only major cardiac events but also other cardiovascular events in diabetic patients.
  • CS are more prevalent in diabetic patients over 65, of male gender, and with multiple risk factors.
Abstract

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...